SARS-CoV-2 Spike Glycoprotein (D614G Mutation)

Product Graph
611€ (100 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
SARS-CoV-2 Spike Glycoprotein (D614G Mutation)
category
Proteins and Peptides
provider
Abbexa
reference
abx169319
tested applications
WB

Description

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Spike Glycoprotein, D614G Variant is a full-length recombinant protein expressed in HEK293 cells. It contains the foldon trimerization motif, mutated Furin recognition site and 2 stabilising mutations (K986P and V987P), based on/modified from Amanat et al, 2020.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Proteins and Peptides
Immunogen Target
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Glycoprotein
Host
HEK293 cells
Origin
Human
Conjugation
Unconjugated
Observed MW
Molecular Weight: Calculated MW: 137 kDa  Observed MW (SDS-PAGE): 190 kDa

Sequence Fragment: 16-1213 AA.

Tag: C-terminal 8 His tag
Expression
Recombinant
Purity
> 90% (SDS-PAGE)
Purification
Purified by affinity chromatography.
Size 1
100 µg
Form
Liquid
Tested Applications
WB
Buffer
PBS, containing 20% glycerol.
Availability
Shipped within 5-7 working days.
Storage
Aliquot and store between -20 °C and -80 °C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
P0DTC2
Background
Protein D614G Mutation
Status
RUO
Note
This product is for research use only.   Not for human consumption, cosmetic, therapeutic or diagnostic use.

Descripción

Related Products
abx169319
SARS-CoV-2 Spike Glycoprotein (D614G Mutation)
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Spike Glycoprotein, D614G Variant is a full-length recombinant protein expressed in HEK293 cells. It contains the foldon trimerization motif, mutated Furin recognition site and 2 stabilising mutations (K986P and V987P), based on/modified from Amanat et al, 2020.
Ver Producto